Researchers at Hospital for Special Surgery (HSS) have launched a pilot study to see how a drug that treats several related autoimmune disorders affects the skeleton
All news from Anaesthesiology
Two new research studies demonstrate that imaging technologies can help to diagnose and detect the progression of glaucoma, one of the leading causes of blindness in the U.S. When diagnosed early, vision loss from glaucoma can be slowed or prevented
Amniotic fluid, the liquid surrounding the fetus, can be routinely obtained without harming the mother or the baby. Previously, Prof. Dr. Adjaye's team and others demonstrated that amniotic fluid contains mesenchymal stem cells with great differentiation and regenerative potential
Penn Medicine researchers have used CRISPR/Cas9 gene editing technology to isolate a key genetic feature that could cause resistance to PARP inhibitors in patients with ovarian cancer—and they've also proven they have a way to see that feature using PET imaging
Federal advisers dealt a setback to the developers of the experimental medicine stannsoporfin for newborns who cannot quickly clear bilirubin and thus risk developing jaundice, by a 21-3 vote recommending rejection of manufacturer Mallinckrodt's application for approval of the drug.
According to the research, a brain-imaging study offers new support for the idea that infants can accurately track other people's beliefs
Kessler Foundation, a leader in rehabilitation research, has partnered with Virtualware Group, an international leader in immersive and interactive technologies, to create a virtual reality (VR) based treatment for spatial neglect, the most common spatial deficit after stroke.
The treatment called VR-SRT System, which will be under direction of Peii Chen, is an intervention that enhances therapy participation through a safe, interactive, and game-like VR environment. The flexibility of the VR-SRT System allows the tool to be implemented in various clinical settings and the home.
When current literature is reviewed, researchers found that factors that influence renal function after partial nephrectomy, are multifactorial
Chronic obstructive pulmonary disease (COPD)is believed to be the third most common cause of death worldwide. However, because the underlying mechanism is still largely unknown, today's treatments can only slow progression of the disease.
Scientists have now reported a previously unknown pathogenic mechanism, which they have already been able to prevent in the laboratory. Their findings are reported in EMBO Molecular Medicine.
Researchers from Duke University, Massachusetts General Hospital and the International Centre for Diarrheal Disease Research in Dhaka, Bangladesh have used machine learning algorithms to spot patterns within communities of bacteria living in the human gut that no human would ever be able to pick out
Researchers at Li Ka Shing Faculty of Medicine of The University of Hong Kong (HKU) have successfully demonstrated the use of human induced pluripotent stem cells (hiPSCs) from patients' skin cells for therapeutic drug testing.
The success of the research implies that scientists are one step closer to applying stem cells in precision medicine in treating patients suffering from rare hereditary diseases.
The project was implemented in accordance with the request of the Government of Russian Federation on the evaluation of non-medicinal nicotine products. The inter-agency research group was based at the Semashko National Scientific Research Institute of Public Health